A sustained-release injection device for aquatic animal immunopolysaccharides

By designing a support frame and lifting components for an aquatic animal immunopolysaccharide sustained-release injection device, the problem of inconvenient injection in aquatic animals has been solved. Stable lifting and precise positioning have been achieved, improving the accuracy and efficiency of injection and reducing manpower input.

CN224975028UActive Publication Date: 2026-11-17HAINAN PROVINCIAL SEED IND LAB +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202521280116.5
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-06-23
Publication Date
2026-11-17
Estimated Expiration
2035-06-23

AI Technical Summary

Technical Problem

Existing methods for sustained-release injection of immunopolysaccharides in aquatic animals are inconvenient to fix, resulting in excessive manpower investment, cumbersome operation, and reduced injection efficiency.

Method used

A sustained-release injection device for aquatic animal immunopolysaccharides, including a support frame and a lifting assembly, was designed. The support frame and lifting assembly enable stable lifting and precise positioning of the injection mechanism. A binding mechanism is provided to fix the aquatic animal, and a pre-tightening component is used to smooth the skin and ensure vertical needle insertion.

Benefits of technology

It improves the accuracy and efficiency of injection, reduces the difficulty of operation and manpower input, avoids damage caused by needle tilting during insertion, and enhances the stability and efficiency of the injection process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224975028U_ABST
    Figure CN224975028U_ABST
Patent Text Reader

Abstract

This utility model discloses a sustained-release injection device for aquatic animal immunopolysaccharides, relating to the field of sustained-release injection technology for aquatic animal immunopolysaccharides. It includes a support frame, which comprises a base and a lifting assembly. The fixed end of the lifting assembly is mounted on one side of the base, and the movable end of the lifting assembly is equipped with an injection mechanism. A binding mechanism for securing the aquatic animal is mounted on the other side of the base. The lifting assembly drives the injection mechanism to complete the lifting operation, with the injection mechanism located directly above the binding mechanism. This sustained-release injection device for aquatic animal immunopolysaccharides, through the design of the support frame and lifting assembly, achieves stable lifting and precise positioning of the injection mechanism, improving the accuracy and efficiency of injection. The addition of the binding mechanism effectively secures the aquatic animal during injection, reducing operational difficulty and manpower input, thereby improving injection efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of sustained-release injection technology of aquatic animal immune polysaccharides, and in particular to a sustained-release injection device for aquatic animal immune polysaccharides. Background Technology

[0002] Aquatic animal immunopolysaccharide sustained-release injection is an immune enhancement therapy for aquatic animals.

[0003] Since aquatic animals include fish, shrimp, crabs, etc., injection requires one person to assist in holding them still while another person performs the injection, which is a waste of manpower and the operation is unstable, thus affecting the injection efficiency.

[0004] Therefore, this application provides a sustained-release injection device for aquatic animal immunopolysaccharides to solve the above problems. Utility Model Content

[0005] The purpose of this invention is to provide a sustained-release injection device for aquatic animal immunopolysaccharides, which aims to solve the problems mentioned in the background art regarding the excessive manpower required and cumbersome operation of existing sustained-release injection methods for aquatic animal immunopolysaccharides, which affect injection efficiency.

[0006] To solve the above-mentioned technical problems, the present invention adopts the following technical solution:

[0007] This utility model provides a sustained-release injection device for aquatic animal immune polysaccharides, including a support frame, the support frame including a base and a lifting assembly, the fixed end of the lifting assembly is installed on one side of the base, the movable end of the lifting assembly is installed with an injection mechanism, and the other side of the base is installed with a binding mechanism for binding aquatic animals, the lifting assembly is used to drive the injection mechanism to complete the lifting operation, and the injection mechanism is located directly above the binding mechanism.

[0008] Optionally, the lifting assembly includes a fixed cylinder, a lifting cylinder, a screw, and a motor. The motor is mounted on the base, and the fixed cylinder is mounted on the base via a bracket and located directly above the motor. The screw is rotatably disposed inside the fixed cylinder, and the bottom end of the screw passes through the bottom wall of the fixed cylinder and is connected to the output shaft of the motor. The lifting cylinder is slidably connected to the top of the fixed cylinder and threadedly connected to the screw. When the motor is working, it drives the screw to rotate, and the rotation of the screw drives the lifting cylinder to move axially along the fixed cylinder.

[0009] Optionally, the injection mechanism includes a connecting rod, a syringe, a piston rod, a handle, a hinge rod, and a cross arm;

[0010] One end of the connecting rod is mounted on the side wall of the lifting cylinder, and the other end is connected to the syringe, which is located below the connecting rod.

[0011] The cross arm is installed on the side wall of the lifting cylinder, and the cross arm is located directly above the connecting rod;

[0012] One end of the hinge rod is hinged to the cross arm via a hinge seat, and the other end of the hinge rod is rotatably connected to the handle;

[0013] The bottom end of the piston rod is movably inserted into the syringe, and the top end of the piston rod is hinged to the middle of the handle after passing through the pre-set through holes on the connecting rod and the cross arm in sequence.

[0014] Optionally, it also includes a pre-tightening element for flattening the skin at the injection site of the target animal, the pre-tightening element being mounted at the bottom of the connecting rod and located around the syringe;

[0015] The pretensioning component includes a collar, a fixing rod, a pressure ring, and a spring; both ends of the spring are connected to the collar and the connecting rod, respectively; the collar is sleeved on the outside of the syringe, and the collar and the syringe are slidably connected.

[0016] The pressure ring is installed below the collar via the fixing rod, and the pressure ring is located below the syringe; the center of the pressure ring has a through hole for the needle of the syringe to pass through.

[0017] Optionally, multiple springs are provided and evenly distributed circumferentially along the syringe.

[0018] Optionally, multiple fixing rods are provided and are evenly distributed around the circumference of the syringe.

[0019] Optionally, a limiting ring is also installed on the fixing rod, the limiting ring being located between the collar and the pressure ring.

[0020] Optionally, the binding mechanism includes an elastic strap, a sleeve, and a locking head. The locking head is mounted on the side wall of the base, the sleeve is engaged with the locking head, the elastic strap is U-shaped, and the two arms at the open end of the elastic strap are mounted on both ends of the sleeve.

[0021] Compared with the prior art, the beneficial technical effects of this utility model are as follows:

[0022] This aquatic animal immunopolysaccharide sustained-release injection device, through the design of the support frame and lifting components, achieves stable lifting and precise positioning of the injection mechanism, improving the accuracy and efficiency of injection. The addition of the binding mechanism allows the aquatic animal to be effectively fixed during the injection process, reducing the difficulty of operation and manpower input, thereby improving injection efficiency.

[0023] This aquatic animal immunopolysaccharide sustained-release injection device can flatten the skin at the injection site of the aquatic animal in advance through a pre-tightening component, making it easier for the needle to be inserted and avoiding needle bending caused by tilting during insertion. Attached Figure Description

[0024] The present invention will be further described below with reference to the accompanying drawings.

[0025] Figure 1 This is a schematic diagram of the structure of a sustained-release injection device for aquatic animal immunopolysaccharides according to the present invention;

[0026] Figure 2 for Figure 1 Enlarged structural diagram at point A;

[0027] Figure 3 This is a cross-sectional view of the inside of the fixed cylinder of this utility model.

[0028] Explanation of reference numerals in the attached drawings: 1. Support frame; 2. Injection mechanism; 3. Binding mechanism;

[0029] 11. Base; 12. Lifting assembly; 121. Fixed cylinder; 122. Lifting cylinder; 123. Screw; 124. Motor;

[0030] 21. Connecting rod; 22. Syringe; 23. Piston rod; 24. Handle; 25. Hinge rod; 26. Cross arm; 27. Preload; 271. Collar; 272. Fixing rod; 273. Pressure ring; 274. Spring;

[0031] 31. Elastic pressure strip; 32. Sleeve rod; 33. Clip head. Detailed Implementation

[0032] To make the technical problem to be solved, the technical solution, and the beneficial effects of this utility model clearer, the present utility model will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain this utility model and are not intended to limit this utility model.

[0033] Example 1

[0034] like Figure 1 and Figure 3 As shown, an aquatic animal immunopolysaccharide sustained-release injection device includes a support frame 1, which includes a base 11 and a lifting assembly 12. The fixed end of the lifting assembly 12 is installed on one side of the base 11, and the movable end of the lifting assembly 12 is equipped with an injection mechanism 2. A binding mechanism 3 for binding aquatic animals is installed on the other side of the base 11. The lifting assembly 12 is used to drive the injection mechanism 2 to complete the lifting operation. The injection mechanism 2 is located directly above the binding mechanism 3.

[0035] Specifically, the lifting assembly 12 includes a fixed cylinder 121, a lifting cylinder 122, a screw 123, and a motor 124. The motor 124 is mounted on the base 11. The fixed cylinder 121 is mounted on the base 11 via a bracket and is located directly above the motor 124. The screw 123 is rotatably disposed inside the fixed cylinder 121, and the bottom end of the screw 123 passes through the bottom wall of the fixed cylinder 121 and is connected to the output shaft of the motor 124. The lifting cylinder 122 is slidably connected to the top of the fixed cylinder 121 and is threadedly connected to the screw 123. When the motor 124 is working, it drives the screw 123 to rotate, and the rotation of the screw 123 drives the lifting cylinder 122 to move axially along the fixed cylinder 121.

[0036] Specifically, the injection mechanism 2 includes a connecting rod 21, a syringe 22, a piston rod 23, a handle 24, a hinge rod 25, and a cross arm 26;

[0037] One end of the connecting rod 21 is mounted on the side wall of the lifting cylinder 122, and the other end is connected to the syringe 22, which is located below the connecting rod 21.

[0038] The horizontal arm 26 is installed on the side wall of the lifting cylinder 122, and the horizontal arm 26 is located directly above the connecting rod 21;

[0039] One end of the hinge rod 25 is hinged to the cross arm 26 via a hinge seat, and the other end of the hinge rod 25 is rotatably connected to the handle 24;

[0040] The bottom end of the piston rod 23 is movably inserted into the syringe 22, and the top end of the piston rod 23 is hinged to the middle of the handle 24 after passing through the pre-set through holes on the connecting rod 21 and the cross arm 26 in sequence.

[0041] Specifically, the binding mechanism 3 includes an elastic pressure strip 31, a sleeve rod 32, and a locking head 33. The locking head 33 is installed on the side wall of the base 11, and the sleeve rod 32 is locked onto the locking head 33. The elastic pressure strip 31 is U-shaped, and the two arms at the open end of the elastic pressure strip 31 are installed at both ends of the sleeve rod 32.

[0042] In use, firstly, the aquatic animal is secured to the binding mechanism 3. Then, the syringe 22 of the injection mechanism 2 is adjusted to a suitable height and position using the lifting assembly 12 until the needle of the syringe 22 is inserted into the skin of the aquatic animal, ensuring accurate targeting of the injection site. Next, the operator holds the handle 24 and pushes it downwards. Since one end of the handle 24 is connected to the movable end of the lifting assembly 12 via a hinge rod 25, and the other end is hinged to the top of the piston rod 23, pushing the handle 24 downwards will cause the piston rod 23 to slide downwards within the syringe 22, thereby dispensing the polysaccharide slow-release liquid for injection. Simultaneously, since the piston rod 23 has a cross arm 26 fixedly connected to the movable end of the lifting assembly 12 on its outer side, and the piston rod 23 is slidably connected to the cross arm 26 and the connecting rod 21, this design ensures that the piston rod 23 remains stable during movement and will not shift due to uneven force. After injection, the injection mechanism 2 is raised using the lifting assembly 12, and the aquatic animal on the binding mechanism 3 is released, completing the entire injection process.

[0043] Example 2

[0044] Unlike Example 1, when encountering shellfish, the needle may bend due to tilted insertion, resulting in needle damage and injection failure. Therefore, the syringe 22 is provided with a pre-tightening member 27 installed at the bottom of the connecting rod 21 to flatten the skin at the injection point of the target animal.

[0045] like Figure 2 As shown, specifically, the preload 27 is installed at the bottom of the connecting rod 21 and located around the syringe 22;

[0046] The pretensioning member 27 includes a collar 271, a fixing rod 272, a pressure ring 273, and a spring 274; the two ends of the spring 274 are respectively connected to the collar 271 and the connecting rod 21; the collar 271 is sleeved on the outside of the syringe 22, and the collar 271 and the syringe 22 are slidably connected.

[0047] The pressure ring 273 is installed below the collar 271 via the fixing rod 272, and the pressure ring 273 is located below the syringe 22; the center of the pressure ring 273 has a through hole for the needle of the syringe 22 to pass through.

[0048] Specifically, multiple springs 274 are provided and are evenly distributed circumferentially along the syringe 22.

[0049] Specifically, multiple fixing rods 272 are provided and are evenly distributed around the circumference of the syringe 22.

[0050] Specifically, a limiting ring is also installed on the fixing rod 272, and the limiting ring is located between the collar 271 and the pressure ring 273.

[0051] When the lifting assembly 12 lowers the injection mechanism 2, before injection, the collar 271 of the pre-tightening member 27, under the elastic force of the spring 274, presses against and slightly down the skin of the injection point of the shell animal through the pressure ring 273 connected by the fixing rod 272. Since the spring 274 provides a certain pre-tightening force, the pressure ring 273 can flatten the skin, creating a relatively flat contact surface for the insertion of the needle. When the needle of the syringe 22 contacts the flattened skin, it can be inserted into the animal body more smoothly and vertically, avoiding the problem of needle tilting or bending caused by uneven skin.

[0052] It should be noted that, in this document, relational terms such as "first" and "second" are used only to distinguish one entity or operation from another, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Furthermore, the terms "comprising," "including," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such process, method, article, or apparatus.

[0053] The embodiments described above are merely preferred embodiments of the present utility model and are not intended to limit the scope of the present utility model. Various modifications and improvements made to the technical solutions of the present utility model by those skilled in the art without departing from the spirit of the present utility model should fall within the protection scope defined by the claims of the present utility model.

Claims

1. A sustained-release injection device for aquatic animal immunopolysaccharides, characterized in that: The system includes a support frame (1), which includes a base (11) and a lifting assembly (12). The fixed end of the lifting assembly (12) is installed on one side of the base (11), and the movable end of the lifting assembly (12) is equipped with an injection mechanism (2). The other side of the base (11) is equipped with a binding mechanism (3) for binding aquatic animals. The lifting assembly (12) is used to drive the injection mechanism (2) to complete the lifting operation. The injection mechanism (2) is located directly above the binding mechanism (3).

2. The aquatic animal immunopolysaccharide sustained-release injection device according to claim 1, characterized in that: The lifting assembly (12) includes a fixed cylinder (121), a lifting cylinder (122), a screw (123), and a motor (124). The motor (124) is mounted on the base (11). The fixed cylinder (121) is mounted on the base (11) via a bracket and is located directly above the motor (124). The screw (123) is rotatably disposed inside the fixed cylinder (121). The bottom end of the screw (123) passes through the bottom wall of the fixed cylinder (121) and is connected to the output shaft of the motor (124) via a transmission connection. The lifting cylinder (122) is slidably connected to the top of the fixed cylinder (121) and threadedly connected to the screw (123). When the motor (124) is working, it drives the screw (123) to rotate. The rotation of the screw (123) drives the lifting cylinder (122) to move along the axial direction of the fixed cylinder (121).

3. The aquatic animal immunopolysaccharide sustained-release injection device according to claim 2, characterized in that: The injection mechanism (2) includes a connecting rod (21), a syringe (22), a piston rod (23), a handle (24), a hinge rod (25), and a cross arm (26); One end of the connecting rod (21) is mounted on the side wall of the lifting cylinder (122), and the other end is connected to the syringe (22), which is located below the connecting rod (21); The cross arm (26) is installed on the side wall of the lifting cylinder (122), and the cross arm (26) is located directly above the connecting rod (21); One end of the hinge rod (25) is hinged to the cross arm (26) via a hinge seat, and the other end of the hinge rod (25) is rotatably connected to the handle (24); The bottom end of the piston rod (23) is movably inserted into the syringe (22), and the top end of the piston rod (23) is hinged to the middle of the handle (24) after passing through the pre-set through holes on the connecting rod (21) and the cross arm (26) in sequence.

4. The aquatic animal immunopolysaccharide sustained-release injection device according to claim 3, characterized in that: It also includes a pre-tightening element (27) for flattening the skin at the injection site of the target animal, the pre-tightening element (27) being mounted at the bottom of the connecting rod (21) and located around the syringe (22); The pretensioning component (27) includes a collar (271), a fixing rod (272), a pressure ring (273), and a spring (274); the two ends of the spring (274) are respectively connected to the collar (271) and the connecting rod (21); the collar (271) is sleeved on the outside of the syringe (22), and the collar (271) and the syringe (22) are slidably connected; The pressure ring (273) is installed below the collar (271) via the fixing rod (272), and the pressure ring (273) is located below the syringe (22); the center of the pressure ring (273) has a through hole for the needle of the syringe (22) to pass through.

5. The aquatic animal immunopolysaccharide sustained-release injection device according to claim 4, characterized in that: Multiple springs (274) are provided and are evenly distributed circumferentially along the syringe (22).

6. The aquatic animal immunopolysaccharide sustained-release injection device according to claim 4, characterized in that: The fixing rods (272) are provided in multiple positions and are evenly distributed around the circumference of the syringe (22).

7. The aquatic animal immunopolysaccharide sustained-release injection device according to claim 4, characterized in that: A limiting ring is also installed on the fixing rod (272), and the limiting ring is located between the collar (271) and the pressure ring (273).

8. The aquatic animal immunopolysaccharide sustained-release injection device according to claim 1, characterized in that: The binding mechanism (3) includes an elastic pressure strip (31), a sleeve rod (32) and a locking head (33). The locking head (33) is installed on the side wall of the base (11), and the sleeve rod (32) is locked onto the locking head (33). The elastic pressure strip (31) is U-shaped, and the two arms at the open end of the elastic pressure strip (31) are installed at both ends of the sleeve rod (32).